Browse By Region

Browse By Category
Recent News
By Category: Countermeasures
Soligenix to Present at World Vaccine Congress & Expo – PR Newswire (press release)
Soligenix to Present at World Vaccine Congress & ExpoPR Newswire (press release)Soligenix's lead biodefense products in development are a recombinant subunit vaccine called RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin and VeloThrax™, a vaccine against anthrax exposure. RiVax™ has …and more »
- April 16, 2013
- | Filed under Countermeasures
Soligenix to Present at World Vaccine Congress & Expo – PR Newswire (press release)
Soligenix to Present at World Vaccine Congress & ExpoPR Newswire (press release)Soligenix's lead biodefense products in development are a recombinant subunit vaccine called RiVax™, which is designed to protect against the lethal effects of exposure to ricin toxin and VeloThrax™, a vaccine against anthrax exposure. RiVax™ has …and more »
- April 16, 2013
- | Filed under Countermeasures
Currently Approved Drugs Found Active Against Bioterror Threats in Laboratory
(LabManagerMagazine) In the most extensive screen of its kind, Texas Biomedical Research Institute scientists have demonstrated the feasibility of repurposing already-approved drugs for use against highly pathogenic bacteria and viruses. The pathogens included emerging diseases and potential bioterror threats ranging from anthrax to the Marburg and Ebola viruses. In testing a library of 1,012 Food Read More »
- April 15, 2013
- | Filed under North America, Countermeasures, and Research
Foot and mouth disease
(PakistanDailyTimes) A low-cost vaccine prepared by the operational laboratory of the University of Veterinary and Animal Sciences (UVAS) for foot and mouth diseases of animals has been commercialised as it received Rs 2.2 million orders during July to December of 2012.
- April 15, 2013
- | Filed under South Asia, Countermeasures, and Public Health
Foot and mouth disease – Pakistan Daily Times
Foot and mouth diseasePakistan Daily TimesLAHORE: A low-cost vaccine prepared by the operational laboratory of the University of Veterinary and Animal Sciences (UVAS) for foot and mouth diseases of animals has been commercialised as it received Rs 2.2 million orders during July to December of …and more »
- April 14, 2013
- | Filed under Countermeasures